Title: Carcinoembryonic Antigen (CEA) Market to reach $2.7bn by 2023
1Carcinoembryonic Antigen (CEA) Market share to
grow at 6 CAGR from 2016 to 2023 Global Market
Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2Key Insights from Carcinoembryonic Antigen Market
- Global Carcinoembryonic Antigen Market is set to
register profitable growth in the near future and
surpass USD 2.8 billion by 2023. - This growth is attributed to factors including
consistent technology advancements, development
of novel biomarkers and growing prevalence of
cancer. - Growing demand for minimally invasive diagnostics
procedures is projected to contribute a
significant part in shaping market growth.
Increasing geriatric population is another key
factor to intensify the Carcinoembryonic Antigen
market growth. - The development of novel combination biomarkers
and initiatives by the government concerning
improved diagnostic rates are likely to open
growth avenues for CEA market.
3Continued...
- North America, hinged on the U.S.
Carcinoembryonic Antigen market size, is
predicted to lead the segment with estimations of
USD 800 million in 2016. - Growing awareness about detecting cancer at an
early stage and improved health care services for
cancer therapeutics are anticipated to propel
growth. - Asia-Pacific region driven by India and China is
targeted to foresee growing prevalence of cancer
owing to changes in lifestyle and aging
population in the area. The growth is mainly
attributed to improved treatment facilities and
high disposable income. - Colorectal cancer tops the application segment
and is expected to foresee growth over the
forecast period. Breast cancer segment is likely
to be the most lucrative with estimations of over
USD 460 million at over 7 CAGR during the
projected time frame.
4Germany Carcinoembryonic Antigen (CEA) Market
size, by application, 2012-2023 (USD Million)
5 Browse Full Market Research Report On
Carcinoembryonic Antigen Market _at_
http//bit.ly/2pqae1Q Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/427 https//www.gminsigh
ts.com/request-sample/detail/49
6Table of Content
Chapter 1. Methodology and Scope 1.1.
Research Methodology 1.1.1.
Initial data exploration 1.1.2. Statistical
model and forecast 1.1.3. Industry insights and
validation 1.1.4. Research scope assumptions
1.2. Data Sources 1.2.1.
Primary Sources 1.2.2. Secondary
Sources Chapter 2. Executive Summary 2.1.
Carcinoembryonic antigen industry 3600 synopsis,
2012 - 2023 2.1.1. Business trends 2.1.2.
Application trends 2.1.3. Regional trends
7Chapter 3. Carcinoembryonic antigen Industry
Insights 3.1. Industry segmentation 3.2.
Industry size and forecast, 2012 - 2023 3.3.
Industry impact forces 3.3.1. Growth
drivers 3.3.1.1. Growing elderly population
base 3.3.1.2. Minimally invasive diagnostic
procedure demand 3.3.1.3. Increasing cancer
prevalence 3.3.1.4. Combination biomarker
adoption surge 3.3.1.5. Healthcare
expenditure trends 3.3.1.6. CEA usage in
cancer 3.3.2. Industry pitfalls
challenges 3.3.2.1. Complex regulatory
landscape 3.3.2.2. Ineffectiveness in
detecting cancer at early stages 3.4. Growth
potential benchmarking 3.5. Company market
share analysis, 2015 3.5.1. Strategy
dashboard 3.6. Porters analysis 3.7. PESTEL
analysis
8 Stay In Touch Website www.gminsights.com Soci
al Media